Corbus Pharmaceuticals Holdings (CRBP) Asset Utilization Ratio (2015 - 2022)
Corbus Pharmaceuticals Holdings (CRBP) posted quarterly Asset Utilization Ratio of 0.0 for Q2 2022, down 96.18% year-over-year from 0.03 in Q2 2021, and down 52.38% quarter-over-quarter from 0.0 in Q1 2022.
Corbus Pharmaceuticals Holdings (CRBP) Asset Utilization Ratio (2015 - 2022) Analysis & Trends
Corbus Pharmaceuticals Holdings' Asset Utilization Ratio history runs 8 years deep, the most recent figure standing at 0.0 for Q2 2022.
- In Q2 2022, Asset Utilization Ratio fell 96.18% year-over-year to 0.0; the TTM figure through Jun 2022 stood at 0.0 (down 96.18% YoY), while the FY2021 annual figure was 0.01, down 87.29% from the prior year.
- Asset Utilization Ratio for Q2 2022 stood at 0.0, down from 0.0 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.47 in Q3 2019, with the low at 0.29 in Q2 2020.
- The 5-year median for Asset Utilization Ratio is 0.03 (2018), against an average of 0.05.
- The sharpest annual moves came in 2019 and 2020: Asset Utilization Ratio soared 958.8% in 2019, then slumped 179.96% in 2020.
- Corbus Pharmaceuticals Holdings' Asset Utilization Ratio stood at 0.09 in 2018, then dropped by 4.36% to 0.09 in 2019, then tumbled by 40.81% to 0.05 in 2020, then plunged by 84.63% to 0.01 in 2021, then plunged by 85.88% to 0.0 in 2022.
- Business Quant data shows CRBP's Asset Utilization Ratio at 0.0 in Q2 2022, 0.0 in Q1 2022, and 0.01 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | Corbus Pharmaceuticals Holdings | 127.63 Mn | -35.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.02 |
| Jun 30, 2021 | 0.03 |
| Mar 31, 2021 | 0.03 |
| Dec 31, 2020 | 0.05 |
| Sep 30, 2020 | -0.26 |
| Jun 30, 2020 | -0.29 |
| Mar 31, 2020 | 0.09 |
| Dec 31, 2019 | 0.09 |
| Sep 30, 2019 | 0.47 |
| Jun 30, 2019 | 0.37 |
| Mar 31, 2019 | 0.08 |
| Dec 31, 2018 | 0.09 |
| Sep 30, 2018 | 0.04 |
| Jun 30, 2018 | 0.04 |
| Mar 31, 2018 | 0.03 |
| Dec 31, 2017 | 0.05 |
| Sep 30, 2017 | 0.08 |